The award highlights the role of Ubiquinol in supporting cellular energy production and mitigating free radical damage. As the global gap between lifespan and healthspan reaches over a decade, the industry is increasingly prioritizing ingredients that sustain physiological function from preconception through later life. Judges cited the company’s extensive clinical research and strong commercial presence across medical and healthcare sectors as key drivers for the decision.
Tsuyoshi Takakuwa, head of marketing and sales for the APAC region, attributed the success to decades of investment in scientific education and ingredient stability. The company’s patented natural fermentation process has become a cornerstone of its market position, currently supporting over 1,000 nutraceutical brands globally. With this latest win, Kaneka continues to formalize its position in the healthspan market, leveraging a portfolio backed by more than 110 scientific studies and 80 patents.
Comments (0)
No comments yet. Be the first!